EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, DuChemBio Co's enterprise value is ₩207,410 Mil.
DuChemBio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩11,175 Mil. Therefore, DuChemBio Co's EV-to-EBITDA for today is 18.56.
The historical rank and industry rank for DuChemBio Co's EV-to-EBITDA or its related term are showing as below:
XKRX:176750'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -69.29 Med: 15.55 Max: 47.82
Current: 18.56
During the past 8 years, the highest EV-to-EBITDA of DuChemBio Co was 47.82. The lowest was -69.29. And the median was 15.55.
XKRX:176750's EV-to-EBITDA is ranked worse than 64.06% of 715
companies
in the Drug Manufacturers industry
Industry Median: 14.42
vs XKRX:176750: 18.56
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
DuChemBio Co EV-to-EBITDA Historical Data
The historical data trend for DuChemBio Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of DuChemBio Co's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DuChemBio Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where DuChemBio Co's EV-to-EBITDA falls into.
DuChemBio Co EV-to-EBITDA Calculation
DuChemBio Co's EV-to-EBITDA for today is calculated as:
DuChemBio Co's current Enterprise Value is ₩207,410 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DuChemBio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩11,175 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DuChemBio Co (XKRX:176750) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
DuChemBio Co's PE Ratio for today is calculated as:
DuChemBio Co's share price for today is ₩7000.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DuChemBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩150.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of DuChemBio Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:176750 has been successfully added to your